Fairmont Banff Springs Floorplan
This meeting was rescheduled and may have a different Meeting Program and Scholarships/Awards
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
MEETING POSTPONED: The Human Microbiome: Ecology and Evolution (Q3)
Organizer(s) Ruth E. Ley, Alejandro Reyes and C. Jessica Metcalf
February 13—16, 2022
Fairmont Banff Springs • Banff, AB Canada
Abstract Deadline: Nov 12, 2021
Scholarship Deadline: Nov 12, 2021
Discounted Registration Deadline: Dec 14, 2021
Sponsored by Astellas Pharma Inc.
Summary of Meeting:
This Keystone Symposia conference will explore the evolutionary and ecological forces shaping the interplay between the human host and microbiome. The microbiome is implicated in a widening set of disease conditions, yet many questions remain as to how its diversity and composition are assembled and maintained. This program is designed to take on the topic of the microbiome across scales, integrating the latest understanding of human microbiome diversity across time and space, and delving into the molecular interactions that shape the associations. This conference aims to understand how movement of human populations, past and present, shape patterns of microbiome diversity. The program will include sessions on deciphering evolutionary dynamics linking microbiota to the human host, as well as discussions on understanding the co-evolution of humans with the microbiome at level of interactions at the molecular scale. Other topics will assess how interactions between host and microbiome can be harnessed for health. Through integration of patterns, processes and theory derived from human and non-human systems, attendees will gain an integrated view of microbiome diversity across modern human populations, and their interactions in host health.
View Scholarships/Awards
This Keystone Symposia conference will explore the evolutionary and ecological forces shaping the interplay between the human host and microbiome. The microbiome is implicated in a widening set of disease conditions, yet many questions remain as to how its diversity and composition are assembled and maintained. This program is designed to take on the topic of the microbiome across scales, integrating the latest understanding of human microbiome diversity across time and space, and delving into the molecular interactions that shape the associations. This conference aims to understand how movement of human populations, past and present, shape patterns of microbiome diversity. The program will include sessions on deciphering evolutionary dynamics linking microbiota to the human host, as well as discussions on understanding the co-evolution of humans with the microbiome at level of interactions at the molecular scale. Other topics will assess how interactions between host and microbiome can be harnessed for health. Through integration of patterns, processes and theory derived from human and non-human systems, attendees will gain an integrated view of microbiome diversity across modern human populations, and their interactions in host health.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
The meeting will begin on Sunday, February 13 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, February 16 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Thursday, February 17 in order to fully experience the meeting.
SUNDAY, FEBRUARY 13
MONDAY, FEBRUARY 14
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
TUESDAY, FEBRUARY 15
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
WEDNESDAY, FEBRUARY 16
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
THURSDAY, FEBRUARY 17
Conference Program Print | View meeting in 12 hr (am/pm) time
The meeting will begin on Sunday, February 13 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, February 16 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Thursday, February 17 in order to fully experience the meeting.
SUNDAY, FEBRUARY 13
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.
08:00—09:00
Welcome and Keynote Address
Howard Ochman,
University of Texas at Austin, USA
Evolution of the Human Microbiome
Evolution of the Human Microbiome
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
08:00—09:00
Welcome and Keynote Address
Eric G. Pamer,
University of Chicago, USA
Impact of Antibiotic on Resistance Development, the Microbiome and Human Health
Impact of Antibiotic on Resistance Development, the Microbiome and Human Health
09:00—11:15
Host Factors and the Microbiome
Alexandra Zhernakova,
University Medical Center Groningen, Netherlands
Host Genetics in Relation to the Microbiome
Host Genetics in Relation to the Microbiome
Coffee Break
C. Jessica Metcalf,
Princeton University, USA
Demographics and the Human Microbiome
Demographics and the Human Microbiome
Nandita Garud,
University of California, Los Angeles, USA
Comparative Population Genetics in the Human Gut Microbiome
Comparative Population Genetics in the Human Gut Microbiome
Qijun Zhang,
University of Wisconsin-Madison, USA
Short Talk: Systems Genetics Uncovers Microbe-Lipid-Host Connections in the Murine Gut
Short Talk: Systems Genetics Uncovers Microbe-Lipid-Host Connections in the Murine Gut
Faye Chleilat,
Stanford University, USA
Short Talk: Paternal High Protein Diet-induced Intergenerational Effects on Body Composition, Insulin Sensitivity, Epigenetics and the Gut Microbiota
Short Talk: Paternal High Protein Diet-induced Intergenerational Effects on Body Composition, Insulin Sensitivity, Epigenetics and the Gut Microbiota
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
09:00—11:15
Expanding the Source of Chemical Space for Antimicrobial
Man-Wah Tan,
Genentech, Inc., USA
DNA Encoded Macrocycles and Metagenomic Mining for Antibiotic Discovery
DNA Encoded Macrocycles and Metagenomic Mining for Antibiotic Discovery
Coffee Break
David Bikard,
Pasteur Institute and Eligo Bioscience, France
Engineering CRISPR-CAS Systems to Kill Bacteria
Engineering CRISPR-CAS Systems to Kill Bacteria
Davide Corti,
Vir Biotechnology, Switzerland
Advances and Challenges in the Development of Anti-Infective Monoclonal Antibodies
Advances and Challenges in the Development of Anti-Infective Monoclonal Antibodies
Paola Estrada†,
Princeton University, USA
Short Talk: Discovery of Aromatic Polyketides from the Human Microbiome
Short Talk: Discovery of Aromatic Polyketides from the Human Microbiome
Noam Adir†,
Technion, Israel
Short Talk: Lethal Sequences: Development of a Platform for Novel Peptide Antibiotics
Short Talk: Lethal Sequences: Development of a Platform for Novel Peptide Antibiotics
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
14:30—16:30
Panel Discussion
*
Deborah T. Hung,
Broad Institute of MIT & Harvard, USA
Man-Wah Tan,
Genentech, Inc., USA
17:00—19:00
Co-Evolution and Co-Diversification of Microbiota and their Hosts
Andrew Moeller,
Cornell University, USA
Coevolution of Hominids and their Microbiomes
Coevolution of Hominids and their Microbiomes
Katherine R. Amato,
Northwestern University, USA
Diet and the Evolution of the Human Microbiome
Diet and the Evolution of the Human Microbiome
Ran Blekhman,
University of Minnesota, USA
Human Genomics and the Human Microbiome
Human Genomics and the Human Microbiome
Samuel Zimmerman,
Harvard University, USA
Short Talk: Tracking Vertical or Horizontal Transmission History of Human Gut Symbionts with Ancient Microbial Genomes
Short Talk: Tracking Vertical or Horizontal Transmission History of Human Gut Symbionts with Ancient Microbial Genomes
Taichi A. Suzuki,
Max Planck Institute for Developmental Biology, Germany
Short Talk: Codiversification of Gut Microbiota with Humans
Short Talk: Codiversification of Gut Microbiota with Humans
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
17:00—19:00
Novel Approaches to Discover Therapeutics and Overcome AMR
Deborah T. Hung,
Broad Institute of MIT & Harvard, USA
Systems Approach to Antimicrobial Discovery
Systems Approach to Antimicrobial Discovery
Jonathan M. Stokes,
McMaster University, Canada
AI-Driven Antibiotic Discovery: New Weapons Against Old Foes
AI-Driven Antibiotic Discovery: New Weapons Against Old Foes
Houra Merrikh,
Vanderbilt University, USA
Blocking the Evolution of Resistance
Blocking the Evolution of Resistance
David S. Weiss,
Emory University, USA
Novel Ways to Treat MDR Microbes
Novel Ways to Treat MDR Microbes
Tommaso Biancalani,
Genentech, USA
Short Talk: GNEprop: State of the Art Deep Learning Framework for Antibiotic Discovery
Short Talk: GNEprop: State of the Art Deep Learning Framework for Antibiotic Discovery
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—11:00
Controlling the Microbiome for Health
Fredrik Bäckhed,
University of Gothenburg, Sweden
The Microbiome in Metabolic Disease
The Microbiome in Metabolic Disease
Lisa Maier,
University of Tübingen, Germany
Microbe-Drug Interactions
Microbe-Drug Interactions
Coffee Break
Sandrine Claus,
Ysopia Bioscience, France
A New Strain of Christensenella minuta as a Potential Biotherapy for Obesity and Associated Metabolic Diseases
A New Strain of Christensenella minuta as a Potential Biotherapy for Obesity and Associated Metabolic Diseases
Jens Walter,
APC Microbiome Ireland, University College Cork, Ireland
Applying Ecological Theory in Controlling Microbiomes
Applying Ecological Theory in Controlling Microbiomes
Marie Wende,
Helmholtz Centre for Infection Research, Germany
Short Talk: Promoting Gut Decolonization of Multi-Drug Resistant Bacteria via the Microbiome
Short Talk: Promoting Gut Decolonization of Multi-Drug Resistant Bacteria via the Microbiome
Soumaya Zlitni,
Stanford University, USA
Short Talk: Microbial Chatter: A Novel Quorum Sensing System in the Gut Bacterium and Pathogen E. Faecalis
Short Talk: Microbial Chatter: A Novel Quorum Sensing System in the Gut Bacterium and Pathogen E. Faecalis
Mackenzie Gutierrez,
University of Calgary, Canada
Short Talk: Early-life Fungal Colonization Mediates Host Metabolism and White Adipose Tissue Inflammation in Mice
Short Talk: Early-life Fungal Colonization Mediates Host Metabolism and White Adipose Tissue Inflammation in Mice
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
08:00—11:00
Alternatives Approaches to tackle AMR
Annette Vogel,
BioNTech, Germany
TB Vaccine based on mRNA Technology
TB Vaccine based on mRNA Technology
Cesar de la Fuente†,
University of Pennsylvania, USA
Talk Title to be Announced
Talk Title to be Announced
Coffee Break
Kimberly Kline,
University of Geneva, Switzerland
Biofilm and AMR
Biofilm and AMR
Heather Pinkett,
Northwestern University, USA
Transporters in AMR
Transporters in AMR
Uyen Thy Nguyen,
University of Wisconsin Madison, USA
Short Talk: Mining Sustainable Antimicrobials in the Human Skin Microbiome
Short Talk: Mining Sustainable Antimicrobials in the Human Skin Microbiome
Dalton T. Ham,
University Of Western Ontario, Canada
Short Talk: Characterizing Cleavage Activity of CRISPR Guide RNAs in Bacteria to Enhance Strain-specific Elimination from Complex Microbial Populations
Short Talk: Characterizing Cleavage Activity of CRISPR Guide RNAs in Bacteria to Enhance Strain-specific Elimination from Complex Microbial Populations
Jaroslav Zelenka,
University of Chemistry and Technology Prague, Czech Republic
Short Talk: Elimination of Bacterial Biofilms with Antimicrobial Photodynamic Therapy
Short Talk: Elimination of Bacterial Biofilms with Antimicrobial Photodynamic Therapy
17:00—19:00
Host-Virus-Microbiome Interactions (Joint)
Andrew T. Gewirtz,
Georgia State University / Frontiers, USA
Host-Virus-Microbiome Interactions
Host-Virus-Microbiome Interactions
Alejandro Reyes,
Los Andes University, Colombia
Bioinformatics Approaches to Phage-Host Interactions
Bioinformatics Approaches to Phage-Host Interactions
Matthew Henn,
Seres Therapeutics, USA
Microbiome Therapeutics to Combat Antimicrobial Resistance and Modulate Host Immunity
Microbiome Therapeutics to Combat Antimicrobial Resistance and Modulate Host Immunity
Lindsay R. Kalan,
University of Wisconsin Madison, USA
Short Talk: Antifungal Potential of the Skin Microbiome
Short Talk: Antifungal Potential of the Skin Microbiome
Julia Berkson†,
FDA, USA
Short Talk: Immunological and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization
Short Talk: Immunological and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—11:00
Microbe-Microbe Interactions in Shaping the Microbiome
Britt Koskella,
University of California, Berkeley, USA
How Microbial Interactions Maintain Diversity
How Microbial Interactions Maintain Diversity
Carolina Tropini,
University of British Columbia, Canada
How the Host Physical Environment Shapes the Gut Microbiota in Health and Disease
How the Host Physical Environment Shapes the Gut Microbiota in Health and Disease
Coffee Break
Jeff Gore,
Massachusetts Institute of Technology, USA
Modeling Interactions
Modeling Interactions
Kevin Foster,
University of Oxford, UK
Cooperation and Competition in Microbes and the Microbiome
Cooperation and Competition in Microbes and the Microbiome
Anna Sophie Weiss,
Max von Pettenkofer Institute, Germany
Short Talk: Exploring the Interaction Network of a Synthetic Gut Bacterial Community
Short Talk: Exploring the Interaction Network of a Synthetic Gut Bacterial Community
Matthew Barber,
University of Oregon, USA
Short Talk: Evolution of Microbial-Host Cell Adherence at Epithelial Barriers
Short Talk: Evolution of Microbial-Host Cell Adherence at Epithelial Barriers
Caitlin H. Kowalski,
University of Oregon, USA
Short Talk: Antimicrobial Activity of Skin-Resident Fungi Alters Pathogen Adaptation
Short Talk: Antimicrobial Activity of Skin-Resident Fungi Alters Pathogen Adaptation
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
08:00—11:00
Innovations in Rapid Diagnostic to Combat AMR
Pierre Mahé,
Biomerieux, France
Diagnosing AMR through Sequencing
Diagnosing AMR through Sequencing
Julie A. Segre,
National Institutes of Health, USA
Tracking an Emerging Pathogen Candida auris in Nursing Homes with Genomic-Epidemiology
Tracking an Emerging Pathogen Candida auris in Nursing Homes with Genomic-Epidemiology
Coffee Break
Kelly Flentie,
Selux Diagnostics, Inc, USA
Rapid Phenotypic Antibiotic Susceptibility Testing
Rapid Phenotypic Antibiotic Susceptibility Testing
Yoelkys Morales,
Tufts University School of Medicine, USA
Short Talk: Impact of Tissue Mimetic Conditions on Combination Therapy in the Treatment of Multi-drug Resistant Klebsiella
Short Talk: Impact of Tissue Mimetic Conditions on Combination Therapy in the Treatment of Multi-drug Resistant Klebsiella
Skylar Martin,
Harvard School of Public Health, USA
Short Talk: Optimizing Molecular Antimicrobial Susceptibility Tests for Neisseria Gonorrhoeae
Short Talk: Optimizing Molecular Antimicrobial Susceptibility Tests for Neisseria Gonorrhoeae
17:00—18:45
Molecular Cross Talk
Elizabeth L. Johnson,
Cornell University, USA
Sphingolipids in the Infant Gut Microbiome
Sphingolipids in the Infant Gut Microbiome
Ruth E. Ley,
Max Planck Institute for Developmental Biology, Germany
The Interactions between Bacterial Flagellins and Toll-Like Receptor 5
The Interactions between Bacterial Flagellins and Toll-Like Receptor 5
Eric C. Martens,
University of Michigan Medical School, USA
The Bacteroides Capsule in Microbiome Interactions
The Bacteroides Capsule in Microbiome Interactions
Tamia Alisha Harris-Tryon,
University of Texas Southwestern Medical Center, USA
Short Talk: Small Proline-rich Proteins (SPRRs) are Epidermally Produced Antimicrobial Proteins that Defend the Cutaneous Barrier by Direct Bacterial Membrane Disruption
Short Talk: Small Proline-rich Proteins (SPRRs) are Epidermally Produced Antimicrobial Proteins that Defend the Cutaneous Barrier by Direct Bacterial Membrane Disruption
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
17:00—18:45
Challenges and Novel Pathways to Develop Alternative Therapies
Sumathi Nambiar,
Johnson and Johnson, USA
Regulatory Paths and Novel Clinical Endpoints
Regulatory Paths and Novel Clinical Endpoints
Jennifer Schneider,
Global Antibiotic R&D Partnership, USA
Talk Title to be Announced
Talk Title to be Announced
Timothy Jinks,
Wellcome Trust, UK
Novel Antimicrobials to Patient: Creating Sustainable R&D and Marketplace for Antimicrobials
Novel Antimicrobials to Patient: Creating Sustainable R&D and Marketplace for Antimicrobials
Following Session is for MEETING POSTPONED: Novel Approaches Against Emerging Antimicrobial Resistance (Q4)
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
*Session Chair †Invited, not yet responded.
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
|
|
We gratefully acknowledge additional support from these exhibitors at this conference:
|
|
|
|
Please stop by to meet these exhibitors during the conference.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: John Monson,
Director of Corporate Relations, Email: johnm@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Josh May, Director, Technology and Digital Media, Email: joshuam@keystonesymposia.org, Phone:+1 970-262-1179 |
